Pemetrexed Continuation Maintenance versus Conventional Platinum-based Doublet Chemotherapy in EGFR-negative Lung Adenocarcinoma: Retrospective Analysis

被引:0
|
作者
Hwang, I. K. [1 ]
Paik, S. S. [1 ]
Park, M. J. [2 ]
Lee, S. H. [2 ]
机构
[1] Dongnam Inst Radiol & Med Sci, Dept Internal Med, Busan, South Korea
[2] Kyung Hee Univ, Med Ctr, Dept Internal Med, Seoul, South Korea
关键词
pemetrexed; chemotherapy; Platinum;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P2.03-020
引用
收藏
页码:S2134 / S2134
页数:1
相关论文
共 50 条
  • [31] Platinum-Based Versus Non-Platinum-Based Chemotherapy as First Line Treatment of Inoperable, Advanced Gastric Adenocarcinoma: A Meta-Analysis
    Chen, Wei-Wei
    Wang, Feng
    Xu, Rui-Hua
    PLOS ONE, 2013, 8 (07):
  • [32] Quality of life analysis of Pemetrexed versus Erlotinib maintenance in EGFR mutation negative advanced non small cell lung cancer.
    Agarwala, Vivek
    Patil, Vijay Maruti
    Noronha, Vanita
    Joshi, Amit
    Chougule, Anuradha
    Trivedi, Vaishakhi
    Kumar, Rajiv
    More, Sucheta
    Goud, Supriya
    Janu, Amit
    Mahajan, Abhishek
    Prabhash, Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [33] A meta-analysis of platinum-based neoadjuvant chemotherapy versus standard neoadjuvant chemotherapy for triple-negative breast cancer
    Wang, Dong
    Feng, Jiafu
    Xu, Bei
    FUTURE ONCOLOGY, 2019, 15 (23) : 2779 - 2790
  • [34] A retrospective analysis of neoadjuvant platinum-based chemotherapy versus up-front surgery in advanced ovarian cancer
    Steed, H
    Oza, AM
    Murphy, J
    Laframboise, S
    Lockwood, G
    De Petrillo, D
    Sturgeon, J
    Rosen, B
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 : 47 - 53
  • [35] Impact of platinum/pemetrexed versus other platinum-based regimens on adjuvant chemotherapy after radical resection in patients with non-small cell lung cancer.
    Zhai, Xiaoyu
    Wang, Ziping
    Yang, Lu
    Zhu, Yixiang
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [36] DOUBLET COMBINATION OF PLATINUM WITH PEMETREXED FOR ADVANCED NON-SMALL-CELL LUNG CANCER: A RETROSPECTIVE ANALYSIS OF A SINGLE INSTITUTION
    Ponce Aix, Santiago
    Iglesias, Lara
    Antonio Nunez, Juan
    Zugazagoitia, Jon
    Blazquez, Maria
    Cesar, Munoz
    Parrilla, Lucia
    Pernaut, Cristina
    Otero, Irene
    Cortes-Funes, Hernan
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S583 - S584
  • [37] The Relationship Between EGFR Gene Mutation Status and ERCC1 in Lung Adenocarcinoma of Chinese Patients Receiving Platinum-Based Neoadjuvant Chemotherapy
    Ke, Hong-Gang
    Zhou, Xiao-Yu
    Shen, Yi
    You, Qing-Sheng
    Yan, Yu
    Shen, Zhen-Ya
    ONCOLOGY RESEARCH, 2012, 20 (5-6) : 221 - 229
  • [38] Combination Treatment Using an EGFR Tyrosine Kinase Inhibitor plus Platinum-Based Chemotherapy for a Patient with Transformed Small Cell Carcinoma and EGFR-Mutated Lung Adenocarcinoma
    Tambo, Yuichi
    Sone, Takashi
    Kasahara, Kazuo
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (12) : E199 - E200
  • [39] Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer:: the ICON4/AGO-OVAR-2.2 trial
    Parmar, MKB
    Ledermann, JA
    Colombo, N
    du Bois, A
    Delaloye, JF
    Kristensen, GB
    Wheeler, S
    Swart, AM
    Qian, W
    Torri, V
    Floriani, I
    Jayson, G
    Lamont, A
    Tropé, C
    Lederman, JA
    Parmar, MKB
    Mangioni, C
    Torri, V
    Sandercock, J
    Dubois, A
    LANCET, 2003, 361 (9375): : 2099 - 2106
  • [40] Comparative survival analysis of platinum-based adjuvant chemotherapy for early-stage squamous cell carcinoma and adenocarcinoma of the lung
    Hsiao, Shih-Hsin
    Chen, Wan-Ting
    Chung, Chi-Li
    Chou, Yu-Ting
    Lin, Sey-En
    Hong, Shiao-Ya
    Chang, Jer-Hwa
    Chang, Tzu-Hao
    Chien, Li-Nien
    CANCER MEDICINE, 2022, 11 (10): : 2067 - 2078